Proteomics managing director Richard Lipscombe.

Proteomics shares up more than 200%

Shares in Nedlands-based Proteomics International Laboratories skyrocketed on news it had produced and validated a predictive test for the diagnosis of diabetic kidney disease.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/08/18

1 year TSR5 year TSR
169thMejority Capital51%-9%
274thProteomics International Laboratories23%0%
578thTransaction Solutions International-22%12%
737 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$0 Other
$0 Other
$0 Issued
Total value as at the date of the transaction
Source: Morningstar


131st↑Transaction Solutions International$2.3m
132nd↓Proteomics International Laboratories$2.1m
135th↓Mejority Capital$2.1m
237 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Proteomics International Laboratories

353rdRichard Lipscombe$325k
1059thJohn Dunlop$67k
1136thTerry Sweet$55k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer